Skin Diseases Completed Phase 3 Trials for Lebrikizumab (DB11914)

Also known as: Skin Disease / Iatrogenic dermatosis / Disease of skin (disorder) / Skin disorder / Dermatosis / Skin disorder NOS

IndicationStatusPhase
DBCOND0028161 (Skin Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04760314A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic DermatitisTreatment